175 related articles for article (PubMed ID: 34383065)
1. VX-765 ameliorates inflammation and extracellular matrix accumulation by inhibiting the NOX1/ROS/NF-κB pathway in diabetic nephropathy.
Wang X; Wu T; Ma H; Huang X; Huang K; Ye C; Zhu S
J Pharm Pharmacol; 2022 Mar; 74(3):377-386. PubMed ID: 34383065
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
4. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
Zhu X; Shi J; Li H
Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
[TBL] [Abstract][Full Text] [Related]
5. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
6. Plantamajoside inhibits high glucose-induced oxidative stress, inflammation, and extracellular matrix accumulation in rat glomerular mesangial cells through the inactivation of Akt/NF-κB pathway.
Xiao D; Yang R; Gong L; Zhang Y; Xie Y; Ni S
J Recept Signal Transduct Res; 2021 Feb; 41(1):45-52. PubMed ID: 32605460
[TBL] [Abstract][Full Text] [Related]
7. Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats.
Wu JS; Liu Y; Shi R; Lu X; Ma YM; Cheng NN
J Ethnopharmacol; 2014 Nov; 157():126-33. PubMed ID: 25278183
[TBL] [Abstract][Full Text] [Related]
8. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
Chen J; Hu Y; Mou X; Wang H; Xie Z
Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
[TBL] [Abstract][Full Text] [Related]
9. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
Wen S; Deng F; Li L; Xu L; Li X; Fan Q
J Diabetes Investig; 2022 Jan; 13(1):22-33. PubMed ID: 34494385
[TBL] [Abstract][Full Text] [Related]
10. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
11. Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy.
Zheng ZC; Zhu W; Lei L; Liu XQ; Wu YG
Drug Des Devel Ther; 2020; 14():4135-4148. PubMed ID: 33116403
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
[TBL] [Abstract][Full Text] [Related]
13. Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Chem Biol Interact; 2018 Sep; 293():11-19. PubMed ID: 30031708
[TBL] [Abstract][Full Text] [Related]
14. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
16. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
Guo M; Gao J; Jiang L; Dai Y
Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
[TBL] [Abstract][Full Text] [Related]
17. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.
Xie X; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2012 Oct; 362(1-2):183-93. PubMed ID: 22732364
[TBL] [Abstract][Full Text] [Related]
18. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
[TBL] [Abstract][Full Text] [Related]
19. BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells.
Wu X; Pan C; Chen R; Zhang S; Zhai Y; Guo H
Int Immunopharmacol; 2020 Feb; 79():106108. PubMed ID: 31881376
[TBL] [Abstract][Full Text] [Related]
20. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
